Aethlon Medical to merge with North Immunology; PIPE about $180M
Aethlon Medical announced a definitive agreement to merge with North Immunology via a tax-free, two-step reorganization, supported by an approximately $180 million PIPE expected to fund immediately prior to closing.
Aethlon Medical said it has entered a definitive agreement to merge with North Immunology in a tax-free, two-step reorganization. The deal is backed by an approximately 180 million PIPE that is expected to fund immediately before closing. Under the exchange ratio framework, pre-merger North Immunology holders, including the company’s existing investors, will receive shares in the combined company.